UNSPSC 51182415: Zoledronic acid

This classification denotes a bone density conservation agent with the molecular formula C5H10N2O7P2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6XC1PAD3KF, chemically known as phosphonic acid, (1-hydroxy-2-(1h-imidazol-1-yl)ethylidene)bis- but generally known as zoledronic acid, which bears US NIH Compound Identifier 68740. European Medicines Agency schedules Zoledronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00176MIG.

UNSPSC 51182415 Zoledronic acid is a Commodity code that nominally names a single bisphosphonate pharmaceutical product, but recent state and local procurement activity shows no substantive purchasing under this code. The three most recent opportunities posted under this code — athletic training services for municipal fire and police departments (City of Tucson), general medical aid supplies including bandages and antiseptics (City of Tampa Fire Rescue), and a Texas HHS exploratory request for information on direct-to-manufacturer pharmacy contracting — bear no functional relationship to zoledronic acid procurement. State and local governments do source pharmaceuticals including specialty injectables, but the opportunities visible here are unrelated to this specific agent or to osteoporosis and oncology treatment indications where zoledronic acid is clinically indicated. The code shows little relevant recent activity.

Geographic activity is scattered across Texas, Arizona, and Florida based on the three unrelated solicitations, with no pattern suggesting concentrated zoledronic acid purchasing. The City of Tucson RFP (due June 9, 2026) and City of Tampa ITB (posted April 24, 2026, with a response due date of April 9, 2025 that predates the posting) are the only firm opportunities named, neither germane to this pharmaceutical code. The Texas HHS RFI (April 3, 2026) explores pharmacy benefit management capability broadly but does not target zoledronic acid or any specific therapeutic class. Buyers pursuing this Commodity code should verify that actual state and local demand for zoledronic acid exists in their target jurisdictions before investing in compliance and proposal effort, as current posting activity does not reflect procurement of this product.